Yoshihide Ogawa, MD, PhD

CONTACT

Yoshihide Ogawa, MD, PhD

CONTACT

Lead Sponsor

Tokushukai Medical Group

Age

20 - No limit years

Sex

ALL

Healthy Volunteers

No

•1. Recipient:
•* Patients who are on dialysis and are willing to receive a restored kidney from a third party
•* Patients who are eligible for general anesthesia
•* Patients who have given written informed consent to participate in the study
•2. Donor:
•* Patients who have small tumor (size: \<4 cm) in the kidney and have chosen total nephrectomy among all the available treatment options and have permitted to transplant the nephrectomized kidney to a third party upon its surgical restoration
•* Patients who are eligible for general anesthesia
•* Patients who have given written informed consent to participate in the study

•1. Recipient:
•* Patients who have infectious disease, hemorrhagic ulcer, or malignant cancer
•* Patients who have serious vascular lesions (eg. arteriosclerosis, thromboembolic disease) and are currently on treatment
•* Patients who were disapproved by the Institutional Ethics Committee
•2. Donor:
•* Patients who have tested positive for serious infectious disease (eg. HIV, HBV, or HCV)
•* Patients who were diagnosed with malignant lymphoma or sarcoma
•* Patients who were on chemotherapy or radiation therapy for renal cancer prior to the nephrectomy
•* Patients who were disapproved by the Institutional Ethics Committee